novel non-immunological agents currently under investigation for cll
Published 1 year ago • 188 plays • Length 2:36Download video MP4
Download video MP3
Similar videos
-
1:01
cll resistance mechanisms in the era of novel agents
-
1:21
how the concept of fitness in cll has changed with the introduction of novel targeted agents
-
1:22
protacs: potential novel agents for the treatment of cll
-
1:32
novel agent combinations: the future of cll
-
2:18
novel agents in development for the treatment of mcl
-
1:14
promising novel agents in aml: menin inhibitors
-
1:30
exciting new agents in cll
-
1:14
novel inducers of apoptosis in double-refractory cll cells
-
2:13
the importance of novel mouse models in our understanding of cll
-
2:03
novel therapeutic agents in the treatment of hodgkin and non-hodgkin lymphoma
-
1:46
novel agent combinations for cll: ibrutinib, venetoclax, obinutuzumab and zanubrutinib
-
0:59
iwcll 2019 - facilitating the development of novel agents and treatment outcomes
-
3:34
the incidence and clinical correlates of non-immune cytopenia at cll diagnosis
-
3:51
the role of frontline chemoimmunotherapy in the era of novel agents in cll
-
1:51
understanding and overcoming resistance mechanisms to novel agents used in cll
-
1:07
novel agents in cll: the current landscape
-
2:00
associated toxicities of novel therapies for cll
-
1:20
improving patient outcomes in ctcl: clinical collaboration and novel agents
-
3:01
novel promising agents and clinical trials in amyloidosis